PRESS RELEASES

Contacts: Anthony G. Viscogliosi, Viscogliosi Bros, LLC (212) 583-9700 ext. 101
Chris Storer, Creative Partners (203) 952-6403

SMALL BONE INNOVATIONS COMPLETES INTEGRATION OF ACQUIRED COMPANIES AND LICENSED PRODUCTS


- Creates five business units focused on bone and joint repair and trauma in extremities

NEW YORK – November 15, 2005 - Small Bone Innovations, LLC (SBI) announced that it has completed the integration of four companies and two licensed technologies, acquired during the past year, by creating five business units to meet its goal of becoming the global leader in small bone and joint reconstruction and trauma in the upper and lower extremities.
 
The business units are: Arthroplasty; Internal Fixation; External Fixation; Tissue Technology; and International Business.
 
Anthony G. Viscogliosi, Chairman & CEO of SBI, said: “Following the acquisition, in May, of Fixano S.A.S., we began structuring the company to accelerate product innovation and build a comprehensive range of products, working closely with surgeons who share our quest to improve dramatically the quality of patient care.”
 
He noted that SBI has added more than 100 staff and technicians, upgraded its manufacturing processes and is building a global distribution network in 28 countries that includes stocking international distributors, independent commissioned sales agencies, and direct sales representation in France and certain major underserved markets in the U.S.
 
Michael Simpson, COO of SBI added that this business model will ultimately offer surgeons and patients “a single source for the broadest and deepest set of market leading implants, instrumentation and educational tools ever assembled for small bone and joint treatment.”
 
SBI is already offering 42 different product systems across a spectrum of small bone and joint indications. Of a further 25 developmental products, SBI has recently received FDA 510(k) market clearances for its ReFIX™ line of bioresorbable pins and screws, its SBI Universal Hand System™, a modular internal fixation set, and a new distal radius plating system.
 
In addition to the products of the acquired companies, SBI has also begun marketing the Artelon® CMC-I Spacer, for basal thumb osteoarthritis, under a license from Artimplant AB of Sweden that recently was extended to cover four more potential applications in the thumb, wrist and foot.

“There is extensive interest in the Artelon spacer technology due to its tissue-sparing qualities and the fact that, in the case of the CMC-I Spacer, it avoids removal of the trapezial bone, thereby restoring function as well as relieving pain. This technology neatly encapsulates everything that SBI stands for by helping patients lead a better quality of life,” Viscogliosi said.
 
SBI was formally introduced at this year’s American Academy of Orthopaedic Surgeons convention , and was the dominant exhibitor at last month’s annual meeting of the American Society for Surgery of the Hand in San Antonio, TX (Sept. 22-24).
 
SBI’s five business units and their principal product systems are as follows:
 
Arthroplasty: PIP and MCP joint implants; the Avanta Total Wrist; the uHead™ ulnar head implant; and rHead™ and rHead™ Recon radial head implants (SBI offers two radial head options); and. The unit is managed by H. Doug Plunkett, Vice President, Arthoplasty Systems.
 
Internal Fixation Systems: SBI Universal Hand System™ stainless steel modular hand set; the Diamond™ Carpal Fusion Plate; SCS™ Distal Radius Plates (volar and dorsal), and the Carpal Button. The unit is managed by Kevin E. Kiel, Vice President, Internal Fixation Systems.
 
External Fixation Systems: Wide range of VueFIX™ finger, hand, wrist, ankle and general external fixation systems; RingFIX™ circular wire fixation systems for trauma/reconstructive surgery in the foot and ankle. The unit is managed by Alan B. Miller, Vice President, External Fixation Systems.
 
Tissue Technology Systems: Artelon® CMC-I spacer; ReFIX™ bioresorbable screws and pins; Actipore® porous metal biomaterial. The unit is managed by Shawn T. Huxel, Vice President, Tissue Technology.
 
International Business: Sales, marketing and distribution of a CE-marked product portfolio; and manufacturing; based at Bourg-en-Bresse, France. The unit is managed by Jean-Jacques Martin, Vice President, International Business.

About SBI
Small Bone Innovations, LLC (SBI) was founded in 2004 by Viscogliosi Bros. LLC., (VB), the New York-based merchant banking firm that specializes in the musculoskeletal /orthopedic sector. VB created SBI as the first company to focus purely on small bone & joint science. By integrating established companies and professionals in the field, SBI today offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints.

VB’s acquisitions and technology licenses include: Avanta Orthopaedics (hand/wrist/elbow arthroplasty and trauma products – USA); Envision (implant manufacturing – USA); Actipore™ (porous metal technology – Canada); Artelon® (biologically active & biodegradable technology – Sweden); Xtremi-T (resorbable trauma technology – USA); Fixano, S.A.S. (orthopedics, trauma and spine products - France).

For more information on SBI visit: www.totalsmallbone.com

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, VB was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry. Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics sector. The have pioneered innovative financial, strategic and management initiatives for companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.
 
> Back to Press Releases

 

Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.